Rivaroxaban in atrial fibrillation cardioversion: an update

Currently, atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, with a prevalence of about 2–3% in the general population, representing a powerful risk factor for stroke and systemic thromboembolism and increased mortality and morbidity. Restoration of sinus rhythm is an importa...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ther Clin Risk Manag
Egile Nagusiak: Lavalle, Carlo, Straito, Martina, Caroli, Annalisa, Piro, Agostino, Giunta, Giuseppe, Mariani, Marco Valerio, Fedele, Francesco
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove 2019
Gaiak:
Review
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6504667/
https://ncbi.nlm.nih.gov/pubmed/31118649
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S201162
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak